12 November 2013 - Deborah Wilkes
Archived
Sanofi has filed a lawsuit to prevent the US Food and Drug Administration (FDA) releasing details of the labelling and packaging for the OTC version of its Nasacort AQ (triamcinolone acetonide) nasal spray.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.